跳至主要内容
临床试验/CTRI/2024/08/072321
CTRI/2024/08/072321尚未招募不适用

Artificial Intelligence (AI) based assessment and prediction for outcomes of Twin Block appliance therapy in growing patients having Class II malocclusion

Council of Scientific & Industrial Research (CSIR), India1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年8月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
1)This study will provide insight into the prediction of treatment outcomes with TBA.

研究概览

简要总结

The development of a model which can efficiently evaluate the status of treatment, taking multiple associated factors into account, will be time saving and aid in clinical decision making. Any discrepancy between expected outcome obtained from the algorithm and actual result would also assist in evaluating patient compliance. AI would eliminate the inherent subjectivity in planning and possibly obtain more favorable aesthetic and customized outcomes. Using the capabilities and potentials of machine learning and computer vision, data derived precision orthodontic approaches can be facilitated and enhanced.

 To the best of our knowledge, there is no available AI model in literature that assesses and predicts the outcome of Class II malocclusion correction with TBA. Thus, the purpose of this study is to apply artificial intelligence to build a model that can assess and predict the treatment outcome with Twin Block appliance for correction of Class II malocclusion.

Since the treatment success is highly dependent on the timing of treatment, there is immense potential for the algorithm to be incorporated with the radiographic machine software so that timely referral of the patient can be made by the general dentist/ primary health care centres to the orthodontists/ higher specialized centres. Thus, the developed system may be evaluated on data from multiple centres and finally a software (standalone as well as web-based application) can be developed for wide-spread utility.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
9.00 Year(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • Growing patients diagnosed with skeletal Class II malocclusion due to retrognathic mandible (indicated for TBA)
  • Age group: 9-14 years
  • CVMI stage: 2,3,4
  • Positive visual treatment objective (VTO)
  • Positive informed consent/assent for treatment and use of dental records.

排除标准

  • Patients with signs and symptoms of neuromuscular disorders or temporomandibular disorders
  • Patients with history of previous or current orthodontic treatment
  • Compromised physical or mental health.

结局指标

主要结局

1)This study will provide insight into the prediction of treatment outcomes with TBA.

时间窗: 1. Pre-treatment (T0)-Before insertion of Twin block appliance | 2. Mid-treatment or Post myofunctional therapy (T1)-At the end of 9-12 months of TB therapy (completion of Active phase) | 3. Post-treatment (T2)-At the end of treatment period (24 months)

2)This study will help in the development of a model which can efficiently and effectively reduce the prolonged hours spent in diagnosis/treatment planning and aid in clinical decision making. Prognostic factors to be considered during the development of treatment plans and clinical protocols for growing Class II patients will largely help in reducing the burden of orthodontic care.

时间窗: 1. Pre-treatment (T0)-Before insertion of Twin block appliance | 2. Mid-treatment or Post myofunctional therapy (T1)-At the end of 9-12 months of TB therapy (completion of Active phase) | 3. Post-treatment (T2)-At the end of treatment period (24 months)

次要结局

  • 1)It will help the clinicians to understand the pitfalls in rendering treatment & achieving patient compliance since discrepancy in the actual results & predicted outcome can be noted.

研究者

发起方
Council of Scientific & Industrial Research (CSIR), India
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Isha Duggal

Maulana Azad Institute of Dental Sciences

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal- Tonsillitis in Pediatric Patients (DROPSPharyngotonsillitisMedDRA version: 17.1Level: PTClassification code 10049140Term: PharyngotonsillitisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-004002-15-Outside-EU/EEASanofi210
招募中
1 期
Clinical trial to assess the efficacy and tolerability of several escalating doses of clodronate, in patients with painful knee osteoarthritisPatients with painful knee osteoarthritisMedDRA version: 21.1Level: LLTClassification code 10029877Term: OA kneeSystem Organ Class: 100000004859
EUCTR2021-003124-33-ITSPA-SOCIETÀ PRODOTTI ANTIBIOTICI S.P.A.296
进行中(未招募)
1 期
Adaptative, multicenter, randomized, double-blind, parallel-group, placebo controlled, clinical trial, on the efficacy and tolerability of different escalating doses of intra-articular clodronate in patients with painful knee osteoarthritisKnee osteoarthritisMedDRA version: 21.1Level: LLTClassification code: 10023476Term: Knee osteoarthritis Class: 10028395
CTIS2024-511961-12-00Spa Societa Prodotti Antibiotici S.p.A.296
进行中(未招募)
1 期
A Study of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)Primary Sjogren's SyndromeMedDRA version: 21.0Level: LLTClassification code 10040766Term: Sjogren's diseaseSystem Organ Class: 100000004859
EUCTR2021-000665-32-PTJanssen-Cilag International NV150
进行中(未招募)
1 期
A Study of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)Primary Sjogren's SyndromeMedDRA version: 21.0Level: LLTClassification code 10040766Term: Sjogren's diseaseSystem Organ Class: 100000004859
EUCTR2021-000665-32-PLJanssen-Cilag International NV150
Development of an Artificial Intelligence (AI) model... | 临床试验